Member Info for Whisp3rs39

I got 37, haha. Wouldn't believe how much more constructive this place is. Most of those are pure rampers though so not just because someone disagreed, those people tend to stay if remotely valid.

Facts don't go through tinfoil hats though remember...

Hi Casper, i have no idea about timings so won't comment. However, I have a feeling hole 2 won't be announced until fully completed. I 'think' as hole 1 hit mineralisation, the board couldn't trust DL to keep his mouth shut so had to inform the market. Now they have informed the market Red Setter has hit mineralisation, they no longer need to update on each hole. Just my opinion. News getting closer by the hour though.

GLA

They are A LOT more patient than we are. These swings to some seem as make or break moments... It's not, just the market being patient enough to place their orders and wait for the rush to finish.

Lord...

I expect any phase 3 trials to conclude by 2029. SP has reacted to patent filing I agree. Next SP will react to deals being signed giving IMM a much larger MCap.

Doesn't need to pass phase 3 to get a deal. Many deals done during phase 1 & 2... I don't understand your understanding.

Of course the SP will fall if no deal is signed, this is obvious.

What Tim has stated many time and drawn emphasis to is deals will be signed, IMM & potential partners orchestrated for the Patent to be filed on a certain date to conclude negotiations.

A deal or deals have probably been signed this or last week and are with lawyers for vetting.

imo

I'll just like to clarify, I have seen the science, I believe it, imo, phase 3 failed last time due to low numbers and placebo too high to conclude a fair test. They believe they understand why this happened and corrected it. I expect this time phase 3 will be passed.

He pulled this from AI Les?

I'll be honest, ATM, this year, it doesn't matter if it works or not. Deals must be signed or Tim is going to jail. Take that comfort. The risk comes back during phase 3 but where we will be then in terms of company value/SP relative to now.... I'll let you figure that out.

Strongly agree Highland... Top end range is open... obvs will get a better idea when deals start flowing.

Suggesting big orders at 18 now like we had at 13 last week. Each week, these backorders will have to increase in price. Imo, MM's are trying their best to keep market flowing while filling some huge orders that keep on coming.

Tick tick boom.... never seen a share on point for so long... magic.

Where's the bin? Got some rubbish here...

Heading to hit SMA 100 again like last week. Mentioned this yesterday, we will see these pull backs all the way up. Go walk the dog, grab some food, do the washing, tie up those loose ends, ring a friend and family member and enjoy the rise back up tomorrow.

Unfiltered you two trolls for 5 minutes, never again. What the CEO has stated now, will be held accountable for in a UK court of Law.

You clearly have no idea how corporate business works. Spend less time on here and do some research, in a few days you might just start getting a handle on it.

Have a lovely evening.

There's also the CIDP, same company could take both. I give your view a high possibility Nettles and will welcome it with open arms. Was just something my old man picked up on initially (Don't like to agree with him). With the vast range of diseases it can potentially assist with, If IMM can play hard ball and say this is how it is, big corp will go along with it and grab as much as they can in their targeted areas, but we will see. Genuinely interested to find out.

That for me, completely depends on Tim strength as a negotiator and IMM's position. If what we have is accurate, we shouldn't be selling, they should be buying.

I wouldn't mind that deal though. £900m upfront, around 10% royalties, would be in line with the figures I've mentioned before.

Finally Nettles, I disagree with you on something. :)

Depending how this is being negotiated, I think one or two big pharma will take a big portion of the available treatments possibly with some others picking up smaller licence deals for more targeted diseases. Just my opinion though.

While we wait for GG, if you have time, give this a watch (from around 17min). Prof. Sylviane Muller, (CNRS)

I believe Verified improvements have been made since by Dr Sébastien Goudreau (IMM)

https://www.youtube.com/watch?v=ia6p_H3Ppm8

What's odds of this doing 7 green bars on the weekly? ;)

You know, the patent filing explicitly mentions up to 50 autoimmune diseases.... let that sink in...

Royalty % depending, if the product is a hit, that figure can be achieved in about 10 years. I have £4-£7 from mediocre deals by year 10 end (10% discounted NVP, with 5-10% royalties, 10% market share for lupus). Good to dream but also keep re-doing the numbers as we go along through the years and it might not seem as unrealistic as it does now. Remember also, all talk so far is only accounting for P140.

Scaring the pants off me. I'm sure there is something I've overlooked (we all know the general risks), no way am I ever this lucky.